14 July 2022
Top hires for VC & PE portfolio companies Q2-2022
Search Highlights
Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Advanced machine learning tools | US |
| CEO | Drug discovery services | UK |
| CEO | Synthetic biology technologies | UK |
| CEO Switzerland | In/outpatient services | Nordics |
| Chief Scientific Officer | Antibody-drug conjugates (ADCs) | Denmark |
| Chief Medical Officer | Digital therapeutics | Sweden |
| Chief Medical Officer | CNS diseases | Singapore |
| Chief Business Officer | Immuno-oncology and vaccines | Finland |
| Chief Commercial Officer | Contract research organisation | US |
| Commercial Head Europe | A.I.-based neuro-diagnostics | Nordics |
| Head Medicinal Chemistry | Discovery tools | UK |
| VP Operations | Precision medicine technologies | US |
| VP Molecular Pharmacology | RNA interference | US |
| VP Clinical Development | RNA therapeutics | US |
| VP Finance | Immuno-oncology | Switzerland |
| Investment Partner | Private equity investor | France |
Newly opened projects include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Oncology devices | Italy |
| CEO | Diagnostics technology | UK |
| CEO | Immuno-oncology | Belgium |
| Chief Business Officer | Gene therapies | Netherlands |
| Chief Medical Officer | Radiopharmaceuticals | China |
| Chief Medical Officer | Digital therapeutics | France |
| Chief Financial Officer | Genomic technologies | US |
| Chief Commercial Officer US | Molecular cartography | Germany |
| Chief Technology Officer | Contract development organisation | US |
| SVP Research | Gene delivery technologies | US |
| VP Intellectual Property | Protein degradation technology | UK |
| General Manager UK | Digital devices and therapeutics | US |
| Board Director | Advanced reagents | Sweden |
| Chair | Active pharmaceutical ingredients | Switzerland |
Related
-
Events
DTx Europe: London 2024
12 December 2024 – 13 December 2024
-
Placement News
Top hires for VC & PE portfolio companies Q1-2023
11 April 2023
-
Placement News
Top hires for VC & PE portfolio companies Q4-2021
25 January 2022
-
Placement News
Top hires for VC & PE portfolio companies Q2-2021
27 July 2021